Search Results - "Madhankumar, Achuthamangalam B."
-
1
Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms
Published in PloS one (06-09-2019)“…Elevated expression of the iron regulatory protein, ferritin heavy chain 1 (FTH1), is increasingly being associated with high tumor grade and poor survival…”
Get full text
Journal Article -
2
Exosomes impact survival to radiation exposure in cell line models of nervous system cancer
Published in Oncotarget (16-11-2018)“…Radiation is utilized in the therapy of more than 50% of cancer patients. Unfortunately, many malignancies become resistant to radiation over time. We…”
Get full text
Journal Article -
3
MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA
Published in Neuro-oncology (Charlottesville, Va.) (01-05-2016)“…Detection of glioma with MRI contrast agent is limited to cases in which the blood-brain barrier (BBB) is compromised as contrast agents cannot cross the BBB…”
Get full text
Journal Article -
4
Efficacy of interleukin-13 receptor–targeted liposomal doxorubicin in the intracranial brain tumor model
Published in Molecular cancer therapeutics (01-03-2009)“…Human glioblastoma tumors selectively express receptors for interleukin 13 (IL-13). In a previous study, we showed that liposomes, when conjugated with IL-13,…”
Get full text
Journal Article -
5
Tumor Targeted Delivery of an Anti‐Cancer Therapeutic: An In Vitro and In Vivo Evaluation
Published in Advanced healthcare materials (01-01-2021)“…The limited effectiveness of current therapeutics against malignant brain gliomas has led to an urgent need for development of new formulations against these…”
Get full text
Journal Article -
6
MLN8237 treatment in an orthoxenograft murine model for malignant peripheral nerve sheath tumors
Published in Journal of neurosurgery (01-02-2019)“…Malignant peripheral nerve sheath tumors (MPNSTs) are soft-tissue sarcomas arising from peripheral nerves. MPNSTs have increased expression of the oncogene…”
Get full text
Journal Article -
7
Targeting IL-13Rα2 for effective treatment of malignant peripheral nerve sheath tumors in mouse models
Published in Journal of neurosurgery (01-11-2019)“…Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue sarcomas that harbor a high potential for metastasis and have a devastating…”
Get full text
Journal Article -
8
Liposomal delivery of ferritin heavy chain 1
Published in PloS one (06-09-2019)“…Elevated expression of the iron regulatory protein, ferritin heavy chain 1 (FTH1), is increasingly being associated with high tumor grade and poor survival…”
Get full text
Journal Article -
9
Biodegradable Nanoparticles: Tumor Targeted Delivery of an Anti‐Cancer Therapeutic: An In Vitro and In Vivo Evaluation (Adv. Healthcare Mater. 2/2021)
Published in Advanced healthcare materials (20-01-2021)“…This cover art represents a new anti‐cancer nanoformulation that targets the brain glioma tumors, offering a potential treatment for these aggressive tumors…”
Get full text
Journal Article -
10
Abstract 745: Interleukin-13 conjugated quantum dots to identify glioma initiating cells and exosomes
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…High grade brain tumors like glioblastoma multiforme (GBM) and certain other brain metastatic cancers possess high tumor invasive and infiltrating properties…”
Get full text
Journal Article -
11
Targeting IL-13Rα2 for effective treatment of malignant peripheral nerve sheath tumors in mouse models
Published in Journal of neurosurgery (30-11-2018)“…Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue sarcomas that harbor a high potential for metastasis and have a devastating…”
Get full text
Journal Article -
12
Abstract 5521: IL13 linked lipsomal doxorubicin for malignant peripheral nerve sheath tumors
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…We have previously demonstrated the therapeutic effect of interleukin-13 (IL13) linked liposomal doxorubicin (IL13LDXR) on glioma tumors. These tumors…”
Get full text
Journal Article